Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Ernst

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Revista Medica De Chile|July 13, 2018
[Interpreting an atypical clinical case: the timing of events determines the diagnosis and impacts the prognosis of non-Hodgkin lymphomas]Daniel Ernst, Karen Escobar
Acta Psychologica|June 19, 2019
Dwelling on distractors varying in target-distractor similarityGernot Horstmann, Daniel Ernst, Stefanie Becker
Attention, Perception & Psychophysics|June 3, 2016
Perceptual salience captures the eyes on a surprise trialGernot Horstmann, Stefanie Becker, Daniel Ernst
Revista Medica De Chile|September 13, 2017
[Response to ABVD chemotherapeutic protocol in patients with early stage Hodgkin’s lymphoma]Javier Díaz, Katherine Soto, Daniel Ernst
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 8, 2021
Prodrugs and prodrug-activated systems in gene therapySemira Sheikh, Daniel Ernst, Armand Keating
Vision Research|February 24, 2020
Novelty competes with saliency for attentionDaniel Ernst, Stefanie Becker, Gernot Horstmann
Revista Medica De Chile|November 17, 2009
[Fever of unknown origin caused by multiple myeloma. Report of one case]Daniel Ernst, Luis Sanhueza A, Luis Rojas, et al.
Materials (Basel, Switzerland)|July 27, 2022
A New Methodological Approach to the Characterization of Optimal Charging Rates at the Hydrogen Plasma Smelting Reduction Process Part 1: MethodMichael Andreas Zarl, Daniel Ernst, Julian Cejka, et al.
Materials (Basel, Switzerland)|June 24, 2022
A New Methodological Approach on the Characterization of Optimal Charging Rates at the Hydrogen Plasma Smelting Reduction Process Part 2: ResultsDaniel Ernst, Michael Andreas Zarl, Julian Cejka, et al.
Revista Medica De Chile|March 9, 2019
[Cytarabine and hematopoietic cell transplantation for mantle cell lymphoma. Analysis of 20 patients]James Campbell, Sebastián Hurtado, Consuelo Kutz, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Revista Medica De Chile|July 13, 2018
[Interpreting an atypical clinical case: the timing of events determines the diagnosis and impacts the prognosis of non-Hodgkin lymphomas]Daniel Ernst, Karen Escobar
Acta Psychologica|June 19, 2019
Dwelling on distractors varying in target-distractor similarityGernot Horstmann, Daniel Ernst, Stefanie Becker
Attention, Perception & Psychophysics|June 3, 2016
Perceptual salience captures the eyes on a surprise trialGernot Horstmann, Stefanie Becker, Daniel Ernst
Revista Medica De Chile|September 13, 2017
[Response to ABVD chemotherapeutic protocol in patients with early stage Hodgkin’s lymphoma]Javier Díaz, Katherine Soto, Daniel Ernst
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 8, 2021
Prodrugs and prodrug-activated systems in gene therapySemira Sheikh, Daniel Ernst, Armand Keating
Vision Research|February 24, 2020
Novelty competes with saliency for attentionDaniel Ernst, Stefanie Becker, Gernot Horstmann
Revista Medica De Chile|November 17, 2009
[Fever of unknown origin caused by multiple myeloma. Report of one case]Daniel Ernst, Luis Sanhueza A, Luis Rojas, et al.
Materials (Basel, Switzerland)|July 27, 2022
A New Methodological Approach to the Characterization of Optimal Charging Rates at the Hydrogen Plasma Smelting Reduction Process Part 1: MethodMichael Andreas Zarl, Daniel Ernst, Julian Cejka, et al.
Materials (Basel, Switzerland)|June 24, 2022
A New Methodological Approach on the Characterization of Optimal Charging Rates at the Hydrogen Plasma Smelting Reduction Process Part 2: ResultsDaniel Ernst, Michael Andreas Zarl, Julian Cejka, et al.
Revista Medica De Chile|March 9, 2019
[Cytarabine and hematopoietic cell transplantation for mantle cell lymphoma. Analysis of 20 patients]James Campbell, Sebastián Hurtado, Consuelo Kutz, et al.
Pageof 3